Acro Biomedical Co Ltd (ACBM)

Name: Acro Biomedical Co Ltd Financial Statements
Creator: Quarter Results

Healthcare | Biotechnology

Latest reporting period: 2025-09-30

Latest Quarter

2025-09-30

Revenue

$0.0

Net Income

-$118K

Operating Margin

N/A

Free Cash Flow

-$36.7K

Debt / Assets

1,022.5%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for Acro Biomedical Co Ltd (ACBM).
Income Statement (Quarterly)	2025-09-30	2025-06-30	2025-03-31	2023-06-30
Revenue	0	0	0	0
Cost of Revenue	0	0	0	0
Gross Profit	0	0	0	0
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	115,099	13,614	8,934	1,316,425
Operating Expenses	115,099	13,614	8,934	3,194,700
Operating Income	-115,099	-13,614	-8,934	-3,194,700
Interest Expense	2,710	1,948	1,367	789
Income Before Tax	-117,809	-15,562	-10,301	-3,195,489
Income Tax Expense	0	0	0	0
Net Income	-117,809	-15,562	-10,301	-3,195,489
Per Share
EPS	0.00	0.00	0.00	-0.05
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for Acro Biomedical Co Ltd (ACBM).
Income Statement (Annual)	2024-12-31	2022-12-31	2021-12-31	2020-12-31	2019-09-30
Revenue	0	658,500	1,197,500	687,964	1,354,000
Cost of Revenue	0	518,000	938,000	528,560	1,218,600
Gross Profit	0	140,500	259,500	159,404	135,400
Operating Expenses
R&D Expenses	0	0	0	0	0
SG&A Expenses	37,958	5,930,237	2,667,903	289,867	576,953
Operating Expenses	37,958	16,010,237	7,953,078	289,867	576,953
Operating Income	-37,958	-15,869,737	-7,693,578	-130,463	-441,553
Interest Expense	4,339	1,706	4,250	5,082	2,265
Income Before Tax	-42,297	-15,871,443	-7,697,828	-135,545	-443,818
Income Tax Expense	0	-15,869,737	0	-18,092	-73,071
Net Income	-42,297	-15,871,443	-7,697,828	-117,453	-370,747
Per Share
EPS	0.00	-0.26	-0.14	0.00	-0.01
EPS Diluted	0.00	0.00	0.00	0.00	0.00

Balance sheet quarterly history for Acro Biomedical Co Ltd (ACBM).
Balance Sheet (Quarterly)	2024-12-31	2022-12-31	2021-12-31	2020-12-31
Assets
Cash and Cash Equivalents	476	5,852	95,248	18,123
Short Term Investments	0	0	0	0
Net Receivables	0	638,500	598,000	0
Inventory	0	12,000	0	938,000
Total Current Assets	5,076	657,537	706,415	973,353
Property Plant Equipment	26,898	25,719	50,432	24,700
Goodwill and Intangibles	0	0	0	0
Total Assets	31,974	687,486	761,077	998,053
Liabilities
Account Payables	154,460	76,571	26,197	24,734
Short Term Debt	53,796	25,719	24,713	24,500
Total Current Liabilities	326,946	201,116	91,651	312,185
Long Term Debt	0	0	25,719	0
Total Liabilities	326,946	201,116	117,370	312,185
Shareholders Equity
Retained Earnings	-32,657,795	-23,807,925	-7,936,482	-238,654
Total Shareholders Equity	-294,972	486,370	643,707	685,868

Balance sheet annual history for Acro Biomedical Co Ltd (ACBM).
Balance Sheet (Annual)	2024-12-31	2022-12-31	2021-12-31	2020-12-31	2019-09-30
Assets
Cash and Cash Equivalents	476	5,852	95,248	18,123	1,472
Short Term Investments	0	0	0	0	0
Net Receivables	0	638,500	598,000	0	0
Inventory	0	12,000	0	938,000	1,060,000
Total Current Assets	5,076	657,537	706,415	973,353	1,069,464
Property Plant Equipment	26,898	25,719	50,432	24,700	0
Goodwill and Intangibles	0	0	0	0	0
Total Assets	31,974	687,486	761,077	998,053	1,069,464
Liabilities
Account Payables	154,460	76,571	26,197	24,734	18,024
Short Term Debt	53,796	25,719	24,713	24,500	0
Total Current Liabilities	326,946	201,116	91,651	312,185	195,792
Long Term Debt	0	0	25,719	0	0
Total Liabilities	326,946	201,116	117,370	312,185	195,792
Shareholders Equity
Retained Earnings	-32,657,795	-23,807,925	-7,936,482	-238,654	-45,328
Total Shareholders Equity	-294,972	486,370	643,707	685,868	873,672

Cash flow quarterly history for Acro Biomedical Co Ltd (ACBM).
Cash Flow Statement (Quarterly)	2024-12-31	2022-12-31	2021-12-31	2020-12-31
Operating Activities
Net Income	-42,297	-15,871,443	-7,697,828	-117,453
Depreciation & Amortization	0	0	0	0
Stock Based Compensation	0	15,712,400	7,651,417	0
Change in Working Capital	0	9,856	341,296	-89,004
Operating Cash Flow	-36,692	-147,481	299,335	-199,460
Investing Activities
Capital Expenditure	0	0	0	0
Investments	0	0	0	0
Investing Cash Flow	0	0	0	0
Financing Activities
Debt Repayment	0	-58,085	0	0
Common Stock Issued/Repurchased	0	0	0	0
Dividends Paid	0	0	0	0
Financing Cash Flow	36,792	58,085	-222,210	216,672
Summary
Free Cash Flow	-36,692	-147,481	299,335	-199,460
Net Change in Cash	100	-89,396	77,125	17,212

Cash flow annual history for Acro Biomedical Co Ltd (ACBM).
Cash Flow Statement (Annual)	2024-12-31	2022-12-31	2021-12-31	2020-12-31	2019-09-30
Operating Activities
Net Income	-42,297	-15,871,443	-7,697,828	-117,453	-370,747
Depreciation & Amortization	0	0	0	0	0
Stock Based Compensation	0	15,712,400	7,651,417	0	300,089
Change in Working Capital	0	9,856	341,296	-89,004	221,156
Operating Cash Flow	-36,692	-147,481	299,335	-199,460	79,692
Investing Activities
Capital Expenditure	0	0	0	0	0
Investments	0	0	0	0	0
Investing Cash Flow	0	0	0	0	0
Financing Activities
Debt Repayment	0	-58,085	0	0	-186,337
Common Stock Issued/Repurchased	0	0	0	0	0
Dividends Paid	0	0	0	0	0
Financing Cash Flow	36,792	58,085	-222,210	216,672	-79,368
Summary
Free Cash Flow	-36,692	-147,481	299,335	-199,460	79,692
Net Change in Cash	100	-89,396	77,125	17,212	324